null Option on Replimune Group

REPL Stock  USD 11.85  1.71  16.86%   
Replimune's latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.62. The total put volume is at 20.0, with calls trading at the volume of 20.0. This yields a 1.0 put-to-call volume ratio. The Replimune option chain provides detailed quote and price information for the current Replimune Group option contracts. It shows all of Replimune's listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on Replimune

Analyzing Replimune's in-the-money options over time can help investors to take a profitable long position in Replimune regardless of its overall volatility. This is especially true when Replimune's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Replimune's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Replimune's stock while costing only a fraction of its price.

Replimune Group In The Money Call Balance

When Replimune's strike price is surpassing the current stock price, the option contract against Replimune Group stock is said to be in the money. When it comes to buying Replimune's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Replimune Group are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Replimune Current Options Market Mood

Replimune's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Replimune Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Replimune's options investors are not very successful. Replimune's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Replimune contract

Base on the Rule 16, the options market is currently suggesting that Replimune Group will have an average daily up or down price movement of about 0.1% per day over the life of the 2025-03-21 option contract. With Replimune trading at USD 11.85, that is roughly USD 0.012. If you think that the market is fully incorporating Replimune's daily price movement you should consider buying Replimune Group options at the current volatility level of 1.62%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Replimune options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Replimune calls. Remember, the seller must deliver Replimune Group stock to the call owner when a call is exercised.

Replimune Option Chain

When Replimune's strike price is surpassing the current stock price, the option contract against Replimune Group stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Replimune's option chain is a display of a range of information that helps investors for ways to trade options on Replimune. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Replimune. It also shows strike prices and maturity days for a Replimune against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
REPL250321C0000250002.57.7 - 11.57.7In
Call
REPL250321C0000500005.05.5 - 9.05.5In
Call
REPL250321C0000750007.53.5 - 7.03.5In
Call
REPL250321C00010000010.01.3 - 4.81.3In
Call
REPL250321C00012500012.50.8 - 2.90.8Out
Call
REPL250321C00015000015.00.1 - 4.80.1Out
Call
REPL250321C00017500017.50.0 - 4.84.8Out
Call
REPL250321C00020000020.00.0 - 0.90.2Out
 Put
REPL250321P0000250002.50.0 - 0.250.25Out
 Put
REPL250321P0000500005.00.0 - 0.30.3Out
 Put
REPL250321P0000750007.50.0 - 0.250.3Out
 Put
REPL250321P00010000010.00.0 - 4.94.9Out
 Put
REPL250321P00012500112.50.7 - 4.53.2In
 Put
REPL250321P00015000015.01.5 - 5.51.5In
 Put
REPL250321P00017500017.53.6 - 7.03.6In
 Put
REPL250321P00020000020.06.2 - 10.06.2In

Replimune Market Cap Over Time

   Market Cap   
       Timeline  

Replimune Total Stockholder Equity

Total Stockholder Equity

291.74 Million

At this time, Replimune's Total Stockholder Equity is quite stable compared to the past year.

Replimune Corporate Management

Sushil PatelChief OfficerProfile
Colin LoveChief OfficerProfile
Christopher SarchiChief OfficerProfile
Tanya MSChief OfficerProfile
Pamela EspositoChief Business OfficerProfile
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.04)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.